| For Practicing Oncologists |
  See all
 | Articles: Pharmacology/Therapy |
PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer
Journal of Pharmacy and Pharmacology, 07/17/08
Adjuvant therapy with pegylated interferon alfa-2b vs observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
The Lancet, 07/17/08
Randomized Phase III Clinical Trial Designs for Targeted Agents
Clinical Cancer Research, 07/17/08
 | | Sponsor |
Targeted Therapies to Improve Tumor Immunotherapy
Clinical Cancer Research, 07/17/08
Therapeutic Options Against BCR-ABL1 T315I-Positive Chronic Myelogenous Leukemia
Clinical Cancer Research, 07/17/08
Host immune gene polymorphisms in combination with clinical and demographic factors predicts late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era
Blood, 07/17/08
Dendritic cell vaccination and immune monitoring
Cancer Immunology, Immunotherapy, 07/17/08
Modulation of CD59 Expression by Restrictive Silencer Factor–Derived Peptides in Cancer Immunotherapy for Neuroblastoma
Cancer Research, 07/17/08
Enhanced anti-cancer effect of a phosphatidylinositol-3 kinase inhibitor and doxorubicin on human breast epithelial cell lines with different p53 and oestrogen receptor status
International Journal of Cancer, 07/17/08
Phase II study of fulvestrant (faslodex) in castration resistant prostate cancer
The Prostate, 07/16/08
|
|
Receive daily email updates on Pharmacology/Therapy
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
 |
 |
| Sponsor |
|
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
 |
| Sponsor |
|
